Frontal Fibrosing Alopecia: A Review and Practical Guide for Clinicians

    Klementyna Kępińska, Magdalena Jałowska, Monika Bowszyc‐Dmochowska
    Image
    Studysummary This review provides a detailed analysis of frontal fibrosing alopecia, focusing on its prevalence in postmenopausal Caucasian women, associated comorbidities, and potential autoimmune, genetic, hormonal, and environmental factors; it emphasizes the need for improved understanding to enhance diagnosis and treatment. Our plain-language summary of this paper — not a Tressless recommendation.
    Frontal fibrosing alopecia (FFA) mainly affects postmenopausal Caucasian women and is associated with various comorbidities such as hyperlipidaemia, arterial hypertension, osteoporosis, hypothyroidism, depression, and different dermatological disorders. The cause of FFA is thought to be a combination of autoimmune, genetic, hormonal, and environmental factors, including regular use of facial sunscreens and less frequent use of hair dyes and shampoo. FFA can manifest in three specific patterns, each with a different prognosis. Diagnosis is usually made clinically with trichoscopy, but a scalp biopsy is the most reliable method. FFA is considered a variant of lichen planopilaris due to similar histopathological findings, but the clinical presentation is unique and treatment options differ. The most effective treatments for FFA are 5α-reductase inhibitors, intralesional steroids, and hydroxychloroquine. The review emphasizes the importance of a better understanding of FFA for effective disease management.
    Discuss this study in the Community →